Mammographic density parameters and breast cancer tumor characteristics among postmenopausal women

References

• McCormackVA, Dos Santos SilvaI. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159–1169. doi:10.1158/1055-9965.EPI-06-003416775176
   PubMed Web of Science ®Google Scholar
• BagliettoL, KrishnanK, StoneJ, et al. Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. Am J Epidemiol. 2014;179(4):475–483. doi:10.1093/aje/kwt26024169466
   PubMed Web of Science ®Google Scholar
• BertrandKA, ScottCG, TamimiRM, et al. Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2015;24(5):798–809. doi:10.1158/1055-9965.EPI-14-113625716949
   PubMed Web of Science ®Google Scholar
• PotterJD, CerhanJR, SellersTA, et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa women’s health study: how many kinds of breast cancer are there?Cancer Epidemiol Biomarkers Prev. 1995;4(4):319–326.7655325
   PubMed Web of Science ®Google Scholar
• HuangWY, NewmanB, MillikanRC, SchellMJ, HulkaBS, MoormanPG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000;151(7):703–714.10752798
   PubMed Web of Science ®Google Scholar
• ColditzGA, RosnerBA, ChenWY, HolmesMD, HankinsonSE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96(3):218–228. doi:10.1093/jnci/djh02514759989
   PubMed Web of Science ®Google Scholar
• RusieckiJA, HolfordTR, ZahmSH, ZhengT. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev. 2005;29(5):419–426.16185815
   PubMedGoogle Scholar
• MaH, BernsteinL, RossRK, UrsinG. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case–control and a case–case comparison. Breast Cancer Res. 2006;8(4):R39. doi:10.1186/bcr151416846528
   PubMed Web of Science ®Google Scholar
• MaH, BernsteinL, PikeMC, UrsinG. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006;8(4):R43. doi:10.1186/bcr152516859501
   PubMed Web of Science ®Google Scholar
• GaudetMM, PressMF, HaileRW, et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat. 2011;130(2):587–597. doi:10.1007/s10549-011-1616-x21667121
   PubMed Web of Science ®Google Scholar
• TurkozFP, SolakM, PetekkayaI, et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast. 2013;22(3):344–350. doi:10.1016/j.breast.2012.08.00522981738
   PubMed Web of Science ®Google Scholar
• ZivE, TiceJ, Smith-BindmanR, ShepherdJ, CummingsS, KerlikowskeK. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2090–2095.15598766
   PubMed Web of Science ®Google Scholar
• GillJK, MaskarinecG, PaganoI, KolonelLN. The association of mammographic density with ductal carcinoma in situ of the breast: the multiethnic cohort. Breast Cancer Res. 2006;8(3):R30. doi:10.1186/bcr150716796758
   PubMed Web of Science ®Google Scholar
• YangW-T, DrydenM, BroglioK, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111(3):405–410. doi:10.1007/s10549-007-9810-618026834
   PubMed Web of Science ®Google Scholar
• MaH, LuoJ, PressMF, WangY, BernsteinL, UrsinG. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(2):479–485. doi:10.1158/1055-9965.EPI-08-080519190139
   PubMed Web of Science ®Google Scholar
• PhippsAI, LiCI, KerlikowskeK, BarlowWE, BuistDSM. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1643–1654. doi:10.1158/1055-9965.EPI-10-018820501751
   PubMed Web of Science ®Google Scholar
• PhippsAI, BuistDSM, MaloneKE, et al. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012;22(5):340–348. doi:10.1016/j.annepidem.2012.02.00222366170
   PubMed Web of Science ®Google Scholar
• ErikssonL, HallP, CzeneK, et al. Mammographic density and molecular subtypes of breast cancer. Br J Cancer. 2012;107(1):18–23. doi:10.1038/bjc.2012.23422644308
   PubMed Web of Science ®Google Scholar
• AntoniS, SascoAJ, Dos Santos SilvaI, McCormackV. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat. 2013;137(2):337–347. doi:10.1007/s10549-012-2362-423239150
   PubMed Web of Science ®Google Scholar
• PollánM, AscunceN, EderraM, et al. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res. 2013;15(1):R9. doi:10.1186/bcr338023360535
   PubMed Web of Science ®Google Scholar
• MaskarinecG, DartoisL, DelalogeS, HopperJ, Clavel-ChapelonF, BagliettoL. Tumor characteristics and family history in relation to mammographic density and breast cancer: the French E3N cohort. Cancer Epidemiol. 2017;49:156–160. doi:10.1016/j.canep.2017.07.00328697417
   PubMed Web of Science ®Google Scholar
• KrishnanK, BagliettoL, StoneJ, et al. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study. BMC Cancer. 2017;17(1):859. doi:10.1186/s12885-017-3871-729246131
   PubMed Web of Science ®Google Scholar
• YaghjyanL, ColditzGA, CollinsLC, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011;103(15):1179–1189. doi:10.1093/jnci/djr22521795664
   PubMedGoogle Scholar
• DingJ, WarrenR, GirlingA, ThompsonD, EastonD. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J. 2010;16(3):279–289. doi:10.1111/j.1524-4741.2010.00907.x20408823
   PubMed Web of Science ®Google Scholar
• ConroySM, PaganoI, KolonelLN, MaskarinecG. Mammographic density and hormone receptor expression in breast cancer: the multiethnic cohort study. Cancer Epidemiol. 2011;35(5):448–452. doi:10.1016/j.canep.2010.11.01121247819
   PubMed Web of Science ®Google Scholar
• HeusingerK, JudSM, HäberleL, et al. Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. Int J Cancer. 2012;131(11):2643–2649. doi:10.1002/ijc.2759222392346
   PubMed Web of Science ®Google Scholar
• BertrandKA, TamimiRM, ScottCG, et al. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res. 2013;15(6):R104. doi:10.1186/bcr357024188089
   PubMed Web of Science ®Google Scholar
• KerlikowskeK, GardCC, TiceJA, et al. Risk factors that increase risk of estrogen receptor–positive and –negative breast cancer. J Natl Cancer Inst. 2017;109(5):djw276. doi:10.1093/jnci/djx007
   Google Scholar
• AielloEJ, BuistDSM, WhiteE, PorterPL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2005;14(3):662–668. doi:10.1158/1055-9965.EPI-04-013215767347
   PubMed Web of Science ®Google Scholar
• RazzaghiH, TroesterMA, GierachGL, OlshanAF, YankaskasBC, MillikanRC. Association between mammographic density and basal-like and luminal A breast cancer subtypes. Breast Cancer Res. 2013;15(5):R76. doi:10.1186/bcr347024008056
   PubMed Web of Science ®Google Scholar
• BaréM, ToràN, SalasD, et al. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program. Breast Cancer Res Treat. 2015;154(2):403–415. doi:10.1007/s10549-015-3623-926531756
   PubMed Web of Science ®Google Scholar
• SalaE, SolomonL, WarrenR, et al. Size, node status and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol. 2000;10(1):157–161. doi:10.1007/s00330005102010663736
   PubMed Web of Science ®Google Scholar
• PorterGJR, EvansAJ, CornfordEJ, et al. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. Am J Roentgenol. 2007;188(3):676–683. doi:10.2214/AJR.05.195017312053
   PubMed Web of Science ®Google Scholar
• KerlikowskeK, CookAJ, BuistDSM, et al. breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28(24):3830–3837. doi:10.1200/JCO.2009.26.477020644098
   PubMed Web of Science ®Google Scholar
• EvansDGR, WarwickJ, AstleySM, et al. Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res. 2012;5(7):943–951. doi:10.1158/1940-6207.CAPR-11-0458
   Web of Science ®Google Scholar
• GrundyA, RichardsonH, BurstynI, et al. Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med. 2013;70:1–8. doi:10.1136/oemed-2013-10148223248187
   PubMed Web of Science ®Google Scholar
• Velásquez GarcíaHA, SobolevBG, GotayCC, et al. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case–control study. Breast Cancer Res Treat. 2018;170:159–168. doi:10.1007/s10549-018-4737-729516373
   PubMed Web of Science ®Google Scholar
• ByngJW, BoydNF, FishellE, JongRA, YaffeMJ. The quantitative analysis of mammographic densities. Phys Med Biol. 1994;39(10):1629–1638. doi:10.1088/0031-9155/39/10/00815551535
   PubMed Web of Science ®Google Scholar
• GlymourMM, GreenlandS. Causal Diagrams In: RothmanKJ, GreenlandS, editors. Modern Epidemiology. 3rd ed. Philadelphia: Lippencott-Raven Publishers; 2008:183–209.
   Google Scholar
• GreenlandS, PearlJ, RobinsJM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37–48. doi:10.1097/00001648-199901000-000089888278
   PubMed Web of Science ®Google Scholar
• PearlJ. Causality: Models, Reasoning, and Inference. Cambridge: Cambridge University Press; 2000.
   Google Scholar
• TextorJ, HardtJ, KnüppelS. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011;22(5):745. doi:10.1097/EDE.0b013e318225c2be
   PubMed Web of Science ®Google Scholar
• DubinN, PasternackBS. Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol. 1986;123(6):1101–1117. doi:10.1093/oxfordjournals.aje.a1143383706280
   PubMed Web of Science ®Google Scholar
• BeggCB, ZhangZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev. 1994;3(2):173–175.8049640
   PubMed Web of Science ®Google Scholar
• BuurenSV, Groothuis-OudshoornK. Mice : multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1–67. doi:10.18637/jss.v045.i03
   Web of Science ®Google Scholar
• HernánMA, Hernández-DíazS, RobinsJM. A structural approach to selection bias. Epidemiology. 2004;15(5):615–625. doi:10.1097/01.ede.0000091604.32542.9715308962
   PubMed Web of Science ®Google Scholar
• ShrierI, PlattRW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol. 2008;8(1):70. doi:10.1186/1471-2288-8-7018973665
   PubMed Web of Science ®Google Scholar
• ShepherdJA, KerlikowskeK. Do fatty breasts increase or decrease breast cancer risk?Breast Cancer Res. 2012;14(1):102. doi:10.1186/bcr316922277587
   PubMed Web of Science ®Google Scholar